Results 141 to 150 of about 1,751 (155)

Insights from real-world and interventional studies of patients transitioning from sodium oxybate to low-sodium oxybate

Sleep Medicine
W. Macfadden, A.M. Husain, P.C. Zee, D.S. Fuller, S. Candler, C. Bae   +5 more
openaire   +1 more source

Efficacy of Low-Sodium Oxybate in the Treatment of Idiopathic Hypersomnia: Evaluation of Treatment Response Based on the Epworth Sleepiness Scale and Idiopathic Hypersomnia Severity Scale Scores (S6.009)

Neurology, 2023
Russell Rosenberg, Abby Chen, Teresa L. Steininger, Wayne Macfadden, Yves Dauvilliers   +4 more
openaire   +1 more source

Blood pressure changes after treatment with low-sodium oxybate in oxybate-naive patients with narcolepsy or idiopathic hypersomnia: a post hoc analysis

Sleep Medicine
W. Macfadden, S. Candler, D.S. Fuller, T.J. Measey, W.B. White   +4 more
openaire   +1 more source

Idiopathic hypersomnia: the long journey from classification to an efficacious drugCommentary on Morse AM, Dauvilliers Y, Arnulf I, et al. Long-term efficacy and safety of low-sodium oxybate in an open-label extension period of a placebo-controlled, double-blind, randomized withdrawal study in adults with idiopathic hypersomnia. J Clin Sleep Med . 2023;19(10):1811–1822. doi:10.5664/jcsm.10698

Journal of Clinical Sleep Medicine, 2023
Geert Mayer, Andrea Rodenbeck
openaire   +1 more source

Efficacy and Safety of Low-Sodium Oxybate in Narcolepsy Patients With/Without Psychiatric/Neurologic Comorbidities (P12-2.004)

Neurology
Craig Chepke, Andrew Cutler, Nathaniel Watson, Shawn Candler, Douglas Fuller, Thomas Measey, Brian Scheckner, Sarah Akerman   +7 more
openaire   +1 more source

Current knowledge on the pathophysiology of idiopathic hypersomnia and potential mechanisms of action for low-sodium oxybate treatment

Journal of Clinical Sleep Medicine
Logan D. Schneider, Alyssa Cairns, Chad Ruoff, Richard K. Bogan   +3 more
openaire   +1 more source

Effectiveness and Optimization of Low-sodium Oxybate in Participants with Narcolepsy Switching from Sodium Oxybate: Final Data from the Substitution of Equal Grams of Uninterrupted Xyrem to Xywav (SEGUE) Study (P10-9.001)

Neurology
Wayne Macfadden, Eileen Leary, Craig Pfister, Douglas Fuller   +3 more
openaire   +1 more source

Corrigendum to “Effectiveness and tolerability in people with narcolepsy transitioning from sodium oxybate to low-sodium oxybate: Data from the real-world TENOR study” [Sleep Med. 109 (2023) 65–74 ISSN 1389–9457]

Sleep Medicine
Charles J. Bae, Phyllis C. Zee, Eileen B. Leary, Douglas S. Fuller, Wayne Macfadden, Shawn Candler, Teresa L. Steininger, Aatif M. Husain   +7 more
openaire   +1 more source

Efficacy of Low-sodium Oxybate by Baseline Sleep Inertia in a Phase 3 Clinical Study in Participants with Idiopathic Hypersomnia (P10-9.003)

Neurology
Michael Thorpy, Douglas Fuller, Marisa Whalen, Wayne Macfadden, Yves Dauvilliers   +4 more
openaire   +1 more source

Effectiveness and Safety of Low-Sodium Oxybate in Participants With Narcolepsy or Idiopathic Hypersomnia: Top-line Results From the Phase 4 DUET Study (P10-2.008)

Neurology
Logan Schneider, David Plante, Deborah A. Nichols, Teresa Steininger, Douglas S. Fuller, M. Todd Kirby, Sarah Akerman, Jessica Alexander, Chad Ruoff, Alyssa Cairns   +9 more
openaire   +1 more source